Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

Does KRAS mutation cause increased 18 FDG uptake in colorectal carcinoma?

Murat Tuncel, Osman Kupik, Gaye Tezel, Suayib Yalcin and Belkis Erbas
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 635;
Murat Tuncel
1Nuclear Medicine, Hacettepe University Medical School, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osman Kupik
1Nuclear Medicine, Hacettepe University Medical School, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaye Tezel
2Pathology, Hacettepe University, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suayib Yalcin
3Clinical Oncology, Hacettepe University, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belkis Erbas
1Nuclear Medicine, Hacettepe University Medical School, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 635

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Murat Tuncel1,
  2. Osman Kupik1,
  3. Gaye Tezel2,
  4. Suayib Yalcin3 and
  5. Belkis Erbas1
  1. 1Nuclear Medicine, Hacettepe University Medical School, Ankara, Turkey
  2. 2Pathology, Hacettepe University, Ankara, Turkey
  3. 3Clinical Oncology, Hacettepe University, Ankara, Turkey

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: January 2015 to April 2025

AbstractFullPdf
Jan 2015100
Mar 2015200
Aug 2015700
Sep 20151100
Oct 2015100
Nov 2015200
Mar 2016400
May 2016200
Jun 2016500
Aug 2016300
Sep 2016100
Oct 2016200
Nov 2016100
Jan 2017200
Apr 2017100
May 2017100
Jul 2017100
Aug 2017100
Oct 2017200
Nov 2017200
Dec 2017100
Jan 20183300
Feb 2018200
Apr 2018200
May 2018100
Jul 2018100
Aug 2018100
Feb 2019100
Apr 2019100
May 2019100
Nov 2019100
Dec 2019100
Jan 2020100
Sep 2020200
Nov 2020300
Dec 2020400
Jan 2021200
Feb 2021800
Mar 2021800
Apr 2021900
May 20212000
Jun 20211400
Jul 20211200
Aug 20211100
Sep 2021300
Oct 2021200
Nov 2021800
Dec 2021400
Jan 2022400
Feb 2022400
Mar 2022400
Apr 2022200
May 2022300
Jun 2022900
Jul 2022300
Aug 2022300
Sep 20223200
Oct 2022300
Nov 2022500
Jan 2023100
Mar 2023300
Apr 2023100
May 2023100
Jun 2023200
Jul 2023100
Aug 2023100
Sep 2023500
Oct 2023200
Nov 2023100
Dec 2023200
Jan 2024300
Feb 2024200
Mar 2024200
Apr 2024200
May 2024400
Jul 20244800
Aug 20244800
Sep 2024800
Nov 2024200
Dec 2024400
Feb 20251100
Mar 2025600
Apr 2025400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Does KRAS mutation cause increased 18 FDG uptake in colorectal carcinoma?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Does KRAS mutation cause increased 18 FDG uptake in colorectal carcinoma?
Murat Tuncel, Osman Kupik, Gaye Tezel, Suayib Yalcin, Belkis Erbas
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 635;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Does KRAS mutation cause increased 18 FDG uptake in colorectal carcinoma?
Murat Tuncel, Osman Kupik, Gaye Tezel, Suayib Yalcin, Belkis Erbas
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 635;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • PET/CT as a predictor of malignancy in indeterminate lung nodules
  • Mismatch between intratumoral blood perfusion and glucose metabolism in same patients with cancer by 18FDG PET/CT scans: A Pilot human study
  • Diagnosis value of trimoality PET/CT-MR in digestive tract disease
Show more Oncology: Clinical Diagnosis

GI: Colorectal & Liver II

  • Effect of pathological factors on visibility of lymph node metastasis from colorectal cancer with FLT PET/CT
  • Diagnostic value of FDG-PET/CT in predicting KRAS mutation in colorectal cancer
  • 18F-FDG PET for colorectal liver metastases: Metabolic response to preoperative chemotherapy predicts prognosis
Show more GI: Colorectal & Liver II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire